secwatch.observer — SEC 8-K summary
======================================

Issuer:     60 DEGREES PHARMACEUTICALS, INC. (SXTP)
CIK:        0001946563
Form:       8-K
Filed at:   2025-09-09T23:59:59+00:00
Accession:  0001213900-25-085853
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

60 Degrees Pharmaceuticals presents at H.C. Wainwright; no specific updates disclosed in filing
--------------------------------------------------------------------------------

- CEO Geoff Dow scheduled to present to investors starting September 9, 2025.
- Slide deck furnished to investors; filing text does not contain its substantive content.
- No financial figures, guidance, or pipeline milestones provided in the 8-K.
- Company is an emerging growth company listed on Nasdaq under SXTP and SXTPW.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1946563/000121390025085853/0001213900-25-085853-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1946563/000121390025085853/ea0256483-8k_60degrees.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-085853

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer